MIRA INFORM REPORT

 

 

Report Date :

14.05.2013

 

IDENTIFICATION DETAILS

 

Name :

NUVISTA PHARMA LIMITED

 

 

Registered Office :

Mascot Plaza (8th  Floor), 107/A, Sonargaon Janapath, Sector – 7, Uttara C.A, Dhaka–1230

 

 

Country :

Bangladesh

 

 

Date of Incorporation :

17.04.1974

 

 

Com. Reg. No.:

C-4096

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacturer & Seller of Pharmaceuticals Products 

 

 

No. of Employees :

1600

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

Regular 

 

 

Litigation :

Clear 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Bangladesh

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

bangladesh ECONOMIC OVERVIEW

 

In real terms Bangladesh's economy has grown 5.8% per year since 1996 despite political instability, poor infrastructure, corruption, insufficient power supplies, and slow implementation of economic reforms. Bangladesh remains a poor, overpopulated, and inefficiently-governed nation. Although more than half of GDP is generated through the service sector, 45% of Bangladeshis are employed in the agriculture sector with rice as the single-most-important product. Bangladesh's growth was resilient during the 2008-09 global financial crisis and recession. Garment exports, totaling $12.3 billion in FY09 and remittances from overseas Bangladeshis, totaling $11 billion in FY10, accounted for almost 12% of GDP.

 

Source : CIA

 

 

COMPANY DETAILS

 

Name

Nuvista Pharma Limited

Address

Mascot Plaza (8th  Floor), 107/A, Sonargaon Janapath, Sector – 7, Uttara C.A, Dhaka–1230

Country

Bangladesh

Telephone No

880-2-8919811

Fax No

880-2-8915797

E-Mail

 
headoffice@nuvista.com.bd

Website

www.nuvistapharma.com

Established

1964

Company Registration No

C-4096

Registration date

17th April 1974

Legal Status

Private Limited

Issuing Authority

The Register of Joint Stock Companies & Firms, Dhaka

Business Type

Manufacturer & Seller

Status

Satisfactory

Payment Behavior

No complaints have been heard regarding payments 

from local suppliers or banks.

 

 

LOCATIONS

 

Head Office

Mascot Plaza (8th  Floor), 107/A, Sonargaon Janapath, Sector – 7, Uttara C.A, Dhaka–1230

Telephone No

880-2-8919811

Fax No

880-2-8915797

E-Mail

headoffice@nuvista.com.bd

Website

www.nuvistapharma.com

Branch

NIL

Factory

97 – 98, Tongi Industrial Area, Gazipur, Bangladesh

Factory Telephone No

880-2-9802387

Factory Fax No

880-2-9802387

Warehouse

97 – 98, Tongi Industrial Area, Gazipur, Bangladesh

 

DIRECTORS

 

Name

Mr. Akhter M. Chaudhury

Designation

Chairman & Managing Director

Nationality

Bangladeshi

 

 

Name

Mr. Kanai Lal Saha

Designation

Director

Nationality

Bangladeshi

 

 

Name

Mr. Rahbar A. Anwar

Designation

Director

Nationality

Bangladeshi

 

 

Name

Mr. Asif Ahmed

Designation

Director

Nationality

Bangladeshi

 

 

SHAREHOLDERS

 

Name

Mr. Akhter M. Chaudhury

Share Percent

40%

Nationality

Bangladeshi

 

 

Name

Mr. Kanai Lal Saha

Share Percent

20%

Nationality

Bangladeshi

 

 

Name

Mr. Rahbar A. Anwar

Share Percent

20%

Nationality

Bangladeshi

 

 

Name

Mr. Asif Ahmed

Share Percent

20%

Nationality

Bangladeshi

 

BUSINESS DETAILS

 

Line of Business

Manufacturer & Seller

Items Dealing In

Pharmaceuticals Products 

Terms of Purchase

Local: Cash or Credit

Import: Against L/C

Terms of Sale

Local: Cash or Credit

 

 

BANKERS

 

Name

Standard Chartered Bank

Branch

Gulshan Branch

Address

Gulshan, Dhaka

SWIFT

N/A

 

 

FINANCIAL INFORMATION

 

Year

2011

2010

 

2009

Investment

Tk.54 million

Tk.54 million

Tk.52 million

Turnover

Tk.484.6 million

Tk.484 million

Tk.482 million

Liability

NIL

NIL

NIL

Assets

Tk.70 million

Tk.70 million

Tk.67 million

 

 

CAPITAL STRUCTURE

 

Authorized Capital

Tk.100 million

Paid Up Capital

Tk.5 million

Each Share Value

Tk.100.00

 

CURRENCY EXCHANGE RATE

 

Currency

Unit

Bangladeshi Taka (BDT)

 

Great Britain Pound

1

119.0566

U.S Dollar

1

77.8300

European Euro

1

100.9611

 

 

ADVERSE DATA MONITORING

 

Dishonored Checks

No Found

Debt

No Found

Litigation

No Records Found

Performance Defaults

No Records Found

Adverse Press Coverage

No Records Found

Money Laundering

No Records Found

 

 

GENERAL INFORMATION

 

Employees

1,600

Office Area (Sq. Ft)

2,200 sq.ft (own)

Factory Area (Sq. Ft)

2.5  acres of land (own)

Warehouse Area (Sq. Ft)

10,500  sq.ft.(own)

Range of Products

Contraception

4 Marvelon

4 Ovostat Gold

 

Hormone Therapy

4 Livial

4 Orgatril

4 Ovestin

4 Testanon

4 Thyronor

4 Andriol Testocaps

 

Fertility

4 Pregnyl

4 Puregon

 

Anesthesia

4 Esmeron

4 Norcuron

 

Haemostatics

4 Anaroxyl

4 Traxyl

 

Anabolics & Corticoseroids

4 Deca-Durabolin

4 Durabolin

4 Oradexon

4 Adam 33

 

Miscellaneous

4 Visceralgine

4 Linda-S

4 Lynes

4 Zoleta

Major Clients 

4 Local Consumers

Raw Materials From

4 The Netherlands

4 European Countries

4 Japan

4 the USA

Certifications

NIL

Group Name

NIL

Subsidiaries / Affiliates

4 Nuvista Consumer Healthcare Limited

4 Nuvista Animal Health & Crop Care Limited

Member

4 Bangladesh Association of Pharmaceuticals, Dhaka

4 Dhaka Chamber of Commerce & Industries, Dhaka

 

 

BUSINESS TREND & PROSPECT

 

Business Scale           

Fairly Large

Business Trend

Growing

Management Capability

Good

Reputation

Good

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.54.63

UK Pound

1

Rs.83.67

Euro

1

Rs.71.02

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.